PRUDENTIAL FINANCIAL INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that PRUDENTIAL FINANCIAL INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $60.77B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $70.41B | Feb 12, 2026 |
| FY2023 | Dec 31, 2023 | $15.08B | Feb 21, 2024 |
| FY2023 | Sep 30, 2023 | $8.35B | Feb 21, 2024 |
| FY2023 | Jun 30, 2023 | $13.50B | Feb 21, 2024 |
| FY2023 | Mar 31, 2023 | $17.05B | Feb 21, 2024 |
| FY2023 | Dec 31, 2022 | $13.43B | Feb 21, 2024 |
| FY2023 | Sep 30, 2022 | $20.20B | Feb 21, 2024 |
| FY2023 | Jun 30, 2022 | $11.39B | Feb 21, 2024 |
| FY2023 | Mar 31, 2022 | $11.86B | Feb 21, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.58B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $2.73B | Feb 12, 2026 |
| FY2023 | Dec 31, 2023 | $1.32B | Feb 21, 2024 |
| FY2023 | Sep 30, 2023 | ($802.00M) | Feb 21, 2024 |
| FY2023 | Jun 30, 2023 | $511.00M | Feb 21, 2024 |
| FY2023 | Mar 31, 2023 | $1.46B | Feb 21, 2024 |
| FY2023 | Dec 31, 2022 | ($52.00M) | Feb 21, 2024 |
| FY2023 | Sep 30, 2022 | ($92.00M) | Feb 21, 2024 |
| FY2023 | Jun 30, 2022 | ($1.01B) | Feb 21, 2024 |
| FY2023 | Mar 31, 2022 | ($493.00M) | Feb 21, 2024 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2009 | Dec 31, 2009 | $8.99B | Feb 26, 2010 |
| FY2009 | Dec 31, 2008 | $9.27B | Feb 26, 2010 |
| FY2009 | Dec 31, 2007 | $8.82B | Feb 26, 2010 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.27B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $8.50B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $6.51B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $5.16B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $9.81B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $8.37B | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $19.63B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $21.66B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $13.46B | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $14.88B | Feb 15, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $773.74B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $735.59B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $721.21B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $689.03B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $937.58B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $940.72B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $896.55B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $815.08B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $832.14B | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | $783.96B | Feb 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $738.16B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $705.46B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $691.34B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $657.11B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $874.97B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $872.51B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $832.83B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $766.05B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $777.63B | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | $737.87B | Feb 16, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.44B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $27.87B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $27.82B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $30.59B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $61.88B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $67.43B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $63.12B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $48.62B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $54.24B | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | $45.86B | Feb 16, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.09B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.05B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $1.07B | Feb 12, 2026 |
| FY2025 | Dec 31, 2022 | $876.00M | Feb 12, 2026 |
| FY2024 | Dec 31, 2021 | $1.80B | Feb 13, 2025 |
| FY2023 | Dec 31, 2020 | $3.04B | Feb 21, 2024 |
| FY2022 | Dec 31, 2019 | $3.01B | Feb 16, 2023 |
| FY2021 | Dec 31, 2018 | $863.00M | Feb 17, 2022 |
| FY2020 | Dec 31, 2017 | $843.00M | Feb 19, 2021 |
| FY2019 | Dec 31, 2016 | $833.00M | Feb 14, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $34.83B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $33.19B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $32.35B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $31.71B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $36.65B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $30.75B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $32.99B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $30.47B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $28.67B | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | $21.95B | Feb 16, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.71B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $18.50B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $19.42B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $17.25B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $12.89B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $13.70B | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $16.33B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $15.35B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $14.49B | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $14.13B | Feb 15, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 12, 2026 |
| FY2023 | Dec 31, 2023 | 3 | Feb 21, 2024 |
| FY2023 | Sep 30, 2023 | (2) | Feb 21, 2024 |
| FY2023 | Jun 30, 2023 | 1 | Feb 21, 2024 |
| FY2023 | Mar 31, 2023 | 3 | Feb 21, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Feb 21, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Feb 21, 2024 |
| FY2023 | Jun 30, 2022 | (2) | Feb 21, 2024 |
| FY2023 | Mar 31, 2022 | (1) | Feb 21, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 12, 2026 |
| FY2023 | Dec 31, 2023 | 3 | Feb 21, 2024 |
| FY2023 | Sep 30, 2023 | (2) | Feb 21, 2024 |
| FY2023 | Jun 30, 2023 | 1 | Feb 21, 2024 |
| FY2023 | Mar 31, 2023 | 3 | Feb 21, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Feb 21, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Feb 21, 2024 |
| FY2023 | Jun 30, 2022 | (2) | Feb 21, 2024 |
| FY2023 | Mar 31, 2022 | (1) | Feb 21, 2024 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.93B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.89B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $1.85B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $1.82B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $1.81B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $1.77B | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $1.64B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $1.52B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $1.30B | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $1.30B | Feb 15, 2019 |